Screener
Acurx Pharmaceuticals, Inc. ACXP Q4 2025 Annual earnings
Reported March 13, 2026 · Before market open
EPS-$0.31Beat by $0.70
EPS estimate-$1.01
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.45
Versus estimates
Diluted EPS
FAQ
- When did Acurx Pharmaceuticals, Inc. report Q4 2025 earnings?
- Acurx Pharmaceuticals, Inc. (ACXP) reported Q4 2025 earnings on March 13, 2026 before market open.
- What were Acurx Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?
- Acurx Pharmaceuticals, Inc. reported eps of $-0.31 for Q4 2025.
- Did Acurx Pharmaceuticals, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-1.01 by $0.70.
- How did Acurx Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 93.8% from $-0.16.
- Where can I find Acurx Pharmaceuticals, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001104659-26-027052) directly on SEC EDGAR. The filing index links above go to sec.gov.
